Sources and updates, September 24
Sources and updates for the week of September 24 include free at-home tests, funding for Long COVID clinics, wildlife surveillance, and more.
Read MoreSources and updates for the week of September 24 include free at-home tests, funding for Long COVID clinics, wildlife surveillance, and more.
Read MoreIn December 2020, Congress gave the National Institutes of Health $1.2 billion to study Long COVID. But it’s been more than two years, and the RECOVER initiative doesn’t have much to show for that money—besides a growing number of frustrated people in the Long COVID community.
Read MoreSources and updates for the week of April 9 include Omicron boosters, federal Long COVID progress, ventilation improvements in K-12 schools, and more.
Read MoreSources and updates for the week of February 19 include test positivity, healthcare data sharing, and the value of vaccination.
Read MoreThis past Monday, the White House announced that the federal public health emergency for COVID-19 will end in May. While this decision might be an accurate reflection of how most of the U.S. is treating COVID-19 right now, it has massive implications for Americans’ access to tests, treatments, vaccines—and data.
Read MoreOn September 2, 2022, the federal government stopped taking orders for free at-home COVID-19 tests. The day this program ended, I sent a public records request to the federal government asking for data on how many tests were distributed. I just received some data back from my request; here’s what the numbers show.
Read MoreCOVID-19 is still a public health emergency. At the moment, this is true according to both the general definition of this term and official declarations by the federal government. But the latter could change in the coming months, likely leading to more fragmentation in U.S. COVID-19 data.
Read MoreThis past Friday, the White House and the Department of Health and Human Services held a briefing previewing two major reports about Long COVID.
Read MoreLast week, I shared a new page from the Department of Health and Human Services (HHS), reporting statistics on COVID-19 therapeutic distribution in the U.S. The new dataset is a helpful step, but it falls far short of the information we actually need to examine who has access to COVID-19 treatments (particularly Paxlovid) and address potential health equity issues.
Read MoreA record number of COVID-19 patients are now receiving care in U.S. hospitals, according to data from the Department of Health and Human Services (HHS). Even so, reports from the doctors and other staff working in these hospitals—conveyed in the news and on social media—suggest that the HHS data don’t capture the current crisis. The federal data may be reported with delays and fail to capture the impact of staffing shortages, obscuring the fact that many regions and individual hospitals are currently operating at 100% capacity.
Read More